Glycogenic hepatopathy

From WikiMD's Food, Medicine & Wellness Encyclopedia

Glycogenic hepatopathy is a rare and underdiagnosed complication of Type 1 diabetes, characterized by the excessive accumulation of glycogen in the hepatocytes. It was first described in 1930 by Mauriac as a component of Mauriac syndrome, a rare pediatric syndrome associated with poorly controlled type 1 diabetes.

Etiology[edit | edit source]

The exact cause of glycogenic hepatopathy is not well understood. It is believed to be related to poor glycemic control in patients with type 1 diabetes. The condition is thought to result from the rapid fluctuation of blood glucose levels, leading to excessive glycogen storage in the hepatocytes.

Clinical Presentation[edit | edit source]

Patients with glycogenic hepatopathy typically present with hepatomegaly, elevated liver enzymes, and poorly controlled diabetes. The condition is often mistaken for nonalcoholic fatty liver disease (NAFLD), as the clinical presentation and laboratory findings can be similar. However, unlike NAFLD, glycogenic hepatopathy is reversible with improved glycemic control.

Diagnosis[edit | edit source]

The diagnosis of glycogenic hepatopathy is typically made through a combination of clinical history, laboratory findings, and liver biopsy. The liver biopsy will show swollen hepatocytes filled with glycogen, without the inflammation or fibrosis typically seen in NAFLD.

Treatment[edit | edit source]

The primary treatment for glycogenic hepatopathy is improved glycemic control. This can be achieved through a combination of diet, exercise, and medication. In severe cases, insulin therapy may be required. With improved glycemic control, the hepatomegaly and liver enzyme elevations typically resolve within weeks to months.

Prognosis[edit | edit source]

The prognosis for glycogenic hepatopathy is generally good, with most patients experiencing complete resolution of symptoms with improved glycemic control. However, if left untreated, the condition can lead to severe liver damage and potentially liver failure.

See Also[edit | edit source]

Glycogenic hepatopathy Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD